Cardiovascular drug use and differences in the incidence of cardiovascular mortality in elderly Serbian men

Author： Hommerson Paul   Nedeljkovic Srecko   Klungel Olaf   Boer Anthonius   Ostojic Miodrag   Grujic Miodrag   Vojvodic Ni   Bloemberg Bennie   Kromhout Daan  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.27, Iss.2, 2005-04, pp. : 124-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality

By Pfützner Andreas   Forst Thomas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 463-476

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Drug Therapy in the Elderly: Theoretical and Practical Considerations

By Williams B.R.  

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 445-463

Adis International

Access to resources Recommend Favorite

Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

By Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

The Consultant Pharmacist, Vol. 31, Iss. 1, 2016-01 ,pp. : 24-32

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

High cardiovascular drug use in patients with OSAS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Maternal drug use in early pregnancy and infant cardiovascular defect

By Kallen B.A.J.   Otterblad Olausson P.  

Reproductive Toxicology, Vol. 17, Iss. 3, 2003-05 ,pp. : 255-261

Elsevier

Access to resources Recommend Favorite